The University of Missouri–Kansas City is a public research university in Kansas City, Missouri. UMKC is part of the University of Missouri System and one of only two member universities with a medical school. As of 2015, the university's enrollment exceeded 16,000 students.

During the past decade, University of Missouri-Kansas City conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Missouri-Kansas City" #1 sponsor was "University of Missouri, Kansas City" with 8 trials, followed by "National Institute on Drug Abuse (NIDA)" with 4 trials sponsored, "American Lung Association Asthma Clinical Research Centers" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Baylor College of Medicine" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Missouri-Kansas City" #1 collaborator was "University of Missouri, Kansas City" with 4 trials as a collaborator, "Children's Mercy Hospital Kansas City" with 3 trials as a collaborator, "University of Missouri-Columbia" with 3 trials as a collaborator, "National Multiple Sclerosis Society" with 2 trials as a collaborator and "Washington University School of Medicine" with 2 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "University of Missouri-Kansas City" are "Asthma" (3 trials), "Amphetamine-Related Disorders" (2 trials), "Cocaine-Related Disorders" (2 trials), "Relapsing-remitting Multiple Sclerosis" (2 trials) and "Substance-Related Disorders" (2 trials). Many other conditions were trialed in "University of Missouri-Kansas City" in a lesser frequency.

Most popular intervention types in "University of Missouri-Kansas City" are "Drug" (14 trials), "Behavioral" (12 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Brief Education" (2 trials), "Carbamazepine" (2 trials), "Motivational Interviewing-Cognitive Behavioral Therapy" (2 trials), "fluticasone" (2 trials) and "A Faithful Response to COVID-19" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Missouri-Kansas City" are 23 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Missouri-Kansas City". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University of Missouri-Kansas City, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Missouri-Kansas City, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".

University of Missouri-Kansas City has several departments that took part in Clinical trials: "University of Missouri at Kansas City, School of Dentistry" - 2 trials, "UMKC School of Pharmacy" - 2 trials